David Epstein Acquires AgomAb Therapeutics Stock; Cantor Fitzgerald Initiates Coverage
What happened
Director David Epstein purchased 10,000 shares of AgomAb Therapeutics stock on October 21, 2026, at an average price of $8.88 per share, totaling $88,800.00. Following the purchase, his ownership increased to 25,000 shares. Separately, Cantor Fitzgerald began stock coverage on AgomAb Therapeutics. The company last reported earnings of ($0.46) EPS for the quarter on August 6th.
From dailypolitical.com
Why it matters
The acquisition by Director David Epstein was disclosed to the Securities & Exchange Commission. This insider activity, combined with new analyst coverage, may influence investor sentiment regarding AgomAb Therapeutics' valuation and future performance.
From dailypolitical.com
Who's involved
- Cantor FitzgeraldAmerican financial services company that initiated stock coverage on AgomAb Therapeutics.
- David EpsteinDirector of AgomAb Therapeutics who acquired 10,000 shares of the company's stock.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- David EpsteinSpeculative
David Epstein's increased ownership could affect his personal investment returns in AgomAb Therapeutics.
Keep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Analyst provides a high price target for Viking Therapeutics stock.
- Bambusa Therapeutics filed an S-1 registration statement with the SEC to pursue an IPO on Nasdaq, with Cantor Fitzgerald and UBS in the underwriting syndicate.
- Cantor Fitzgerald issued a neutral rating and price target, while Sherry Group Inc. significantly increased its share holdings on October 10, 2026.
- Multiple financial firms, including Cantor Fitzgerald and William Blair, issued rating updates and price targets for various stocks on August 10, 2026.